# Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage IB, Stage II, or Stage IIIB Cervical Cancer

> **NCT00957411** · PHASE2 · COMPLETED · sponsor: **Institut Curie** · enrollment: 76 (actual)

## Conditions studied

- Cervical Cancer

## Interventions

- **BIOLOGICAL:** cetuximab
- **DRUG:** cisplatin

## Key facts

- **NCT ID:** NCT00957411
- **Lead sponsor:** Institut Curie
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2013-11
- **Final completion:** 2014-10
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2025-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00957411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00957411, "Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage IB, Stage II, or Stage IIIB Cervical Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00957411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*